![Cheryl Cui](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Aktive Positionen von Cheryl Cui
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Nest.Bio Ventures
![]() Nest.Bio Ventures Investment ManagersFinance Nest.Bio Ventures (Nest.Bio) is a venture capital firm founded in 2017. The firm is headquartered in Cambridge, Massachusetts. | Gründer | 01.01.2017 | - |
Private Equity Investor | 01.01.2017 | - | |
Bota Biosciences, Inc. | Vorstandsvorsitzender | - | - |
Gründer | - | - | |
Hangzhou Bota Biosciences Co., Ltd.
![]() Hangzhou Bota Biosciences Co., Ltd. Miscellaneous Commercial ServicesCommercial Services Hangzhou Bota Biosciences Co., Ltd. is an industrial biotechnology company founded in 2019. The company is based in Hangzhou, China. Bota Biosciences aims to program biological systems for clean bio-manufacturing. | Vorsitzender | 24.09.2020 | - |
Direktor/Vorstandsmitglied | - | 24.09.2020 | |
Vorstandsvorsitzender | - | 24.09.2020 | |
Rootpath Genomics, Inc.
![]() Rootpath Genomics, Inc. BiotechnologyHealth Technology Rootpath Genomics, Inc. engages in the provision of biotechnology services. It develops personalized T cell therapy platform that bridges precision medicine and cancer immunotherapy. The company was founded by Xi Chen, Le Cong, Yinqing Li, Cheryl Cui, and Ely Porter in 2017 and is headquartered in Cambridge, MA. | Direktor/Vorstandsmitglied | - | - |
HiFiBiO Inc.
![]() HiFiBiO Inc. Pharmaceuticals: MajorHealth Technology HiFiBiO Inc. develops and manufactures pharmaceutical products. It specializes in antibodies, that mobilize the human immune system to combat cancer, autoimmune disorders, and other unmet medical needs. The company was founded by Liang Schweizer, Fred Dom, Andrew Griffiths, David Weitz, Bradley Bernstein, J?r?me Bibette, and Robert Nicol and is headquartered in Paris, France. | Direktor/Vorstandsmitglied | - | - |
Karriereverlauf von Cheryl Cui
Ehemalige bekannte Positionen von Cheryl Cui
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Rootpath Genomics, Inc.
![]() Rootpath Genomics, Inc. BiotechnologyHealth Technology Rootpath Genomics, Inc. engages in the provision of biotechnology services. It develops personalized T cell therapy platform that bridges precision medicine and cancer immunotherapy. The company was founded by Xi Chen, Le Cong, Yinqing Li, Cheryl Cui, and Ely Porter in 2017 and is headquartered in Cambridge, MA. | Gründer | 01.01.2017 | - |
Ausbildung von Cheryl Cui
University of Toronto | Graduate Degree |
Massachusetts Institute of Technology | Doctorate Degree |
Statistik
International
Vereinigte Staaten | 6 |
Kanada | 2 |
China | 2 |
Operativ
Founder | 3 |
Director/Board Member | 3 |
Chief Executive Officer | 2 |
Sektoral
Health Technology | 3 |
Finance | 3 |
Consumer Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Private Unternehmen | 5 |
---|---|
Rootpath Genomics, Inc.
![]() Rootpath Genomics, Inc. BiotechnologyHealth Technology Rootpath Genomics, Inc. engages in the provision of biotechnology services. It develops personalized T cell therapy platform that bridges precision medicine and cancer immunotherapy. The company was founded by Xi Chen, Le Cong, Yinqing Li, Cheryl Cui, and Ely Porter in 2017 and is headquartered in Cambridge, MA. | Health Technology |
Nest.Bio Ventures
![]() Nest.Bio Ventures Investment ManagersFinance Nest.Bio Ventures (Nest.Bio) is a venture capital firm founded in 2017. The firm is headquartered in Cambridge, Massachusetts. | Finance |
Bota Biosciences, Inc. | |
Hangzhou Bota Biosciences Co., Ltd.
![]() Hangzhou Bota Biosciences Co., Ltd. Miscellaneous Commercial ServicesCommercial Services Hangzhou Bota Biosciences Co., Ltd. is an industrial biotechnology company founded in 2019. The company is based in Hangzhou, China. Bota Biosciences aims to program biological systems for clean bio-manufacturing. | Commercial Services |
HiFiBiO Inc.
![]() HiFiBiO Inc. Pharmaceuticals: MajorHealth Technology HiFiBiO Inc. develops and manufactures pharmaceutical products. It specializes in antibodies, that mobilize the human immune system to combat cancer, autoimmune disorders, and other unmet medical needs. The company was founded by Liang Schweizer, Fred Dom, Andrew Griffiths, David Weitz, Bradley Bernstein, J?r?me Bibette, and Robert Nicol and is headquartered in Paris, France. | Health Technology |
- Börse
- Insiders
- Cheryl Cui
- Erfahrung